Last edition
News about "Establishment Inspection Report "
La Chandra Pharmalab Secures US FDA Clearance for Gujarat Hormone API Facility
La Chandra Pharmalab has received a US FDA Establishment Inspection Report (EIR) for its Banaskantha hormone API manufacturing facility, reinforcing its position in regulated markets and advancing India's capabilities in hormone API manufacturing.
Establishment Inspection Report | 03/07/2026 | By News Bureau | 110
Piramal Pharma Completes US FDA Inspection at Lexington Facility
Piramal Pharma receives US FDA EIR with VAI status for its Lexington facility, marking successful closure of inspection and regulatory compliance.
Establishment Inspection Report | 13/04/2026 | By News Bureau | 227
Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility
Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.
Establishment Inspection Report | 15/12/2025 | By News Bureau | 150
Lupin Gets EIR from US FDA for its Somerset Manufacturing Facility
Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset.
Establishment Inspection Report | 24/06/2024 | By Aishwarya | 970
Gland Pharma Receives EIR From USFDA For Dundigal Facility
Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.
Establishment Inspection Report | 25/08/2023 | By Manvi | 894
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy